Merck & Co., Inc. (6MK)
XETR
Closed
Aug 21, 2026
Day's Range
127.1452 wk Range
66.40Overview - 6MK - Merck & Co., Inc.
Key Statistics
Valuation
Enterprise Value
317.65B
P/E (Trailing)
‪120.51‬
PEG Ratio
‪-0.92‬
Price / Sales (TTM)
‪4.82‬
Price / Book
‪8.87‬
EV / EBITDA
‪12.74‬
Profitability
Gross Margin
‪73.53%‬
Profit Margin
‪4.76%‬
Operating Margin
‪-0.24%‬
Return on Assets
‪11.86%‬
Return on Equity
‪6.96%‬
Ownership
Shares Outstanding
2.46B
Float
2.46B
Held by Insiders
‪0.05%‬
Held by Institutions
‪82.75%‬
Price stats
Beta
‪0.21‬
50-Day Avg
‪110.54‬
200-Day Avg
‪99.68‬
Dividends
Payout Ratio
‪268.80%‬
Frequency
Quarterly
Market Cap - 6MK - Merck & Co., Inc.
Peers - 6MK - Merck & Co., Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on XETR.
Profile Summary - 6MK - Merck & Co., Inc.
About
Merck & Co., Inc. operates as a leading healthcare company worldwide, specializing in the research, development, and commercialization of innovative pharmaceutical products and vaccines. Its portfolio features prominent human health pharmaceuticals such as Keytruda for oncology treatments, Welireg for specific cancer…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
